EMERALD THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Nov 2025)
What this means for you
This application is over — abandoned 24 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97068643
- Mark type
- Stylized text
- Filed
- 11 Oct 2021
- Published for opposition
- 23 Aug 2022
- Abandoned
- 24 Nov 2025
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
Owner
- Emerald Therapeutics, Inc., South San Francisco, CA, US
- Emerald Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2025 — SOU EXTENSION 5 GRANTED
- 14 Apr 2025 — SOU EXTENSION 5 FILED
- 31 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2024 — SOU EXTENSION 4 GRANTED
- 03 Oct 2024 — SOU EXTENSION 4 FILED
- 03 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2024 — SOU EXTENSION 3 GRANTED
- 18 Apr 2024 — SOU EXTENSION 3 FILED
- 18 Apr 2024 — SOU TEAS EXTENSION RECEIVED